Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makishima

Showing results (471-480 of 737) with videos related to

Pageof 74
Sort By:
Journal of Oncology|October 5, 2020
CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in NeuroblastomaKiyohiro Ando, Verna Cázares-Ordoñez, Makoto Makishima, et al.
Leukemia|January 17, 2012
CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitorsH Makishima, Y Sugimoto, H Szpurka, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2009
[Design and synthesis of peroxisome proliferator-activated receptor (PPAR) delta agonists and its implication to the driving force to elicit PPAR delta selectivity]Jun-Ichi Kasuga, Takuji Oyama, Izumi Nakagome, et al.
Chemmedchem|February 26, 2008
The first potent subtype-selective retinoid X receptor (RXR) agonist possessing a 3-isopropoxy-4-isopropylphenylamino moiety, NEt-3IP (RXRalpha/beta-dual agonist)Kayo Takamatsu, Atsushi Takano, Nobumasa Yakushiji, et al.
Molecules (Basel, Switzerland)|November 30, 2019
Synthesis and In Vitro Evaluation of Novel Liver X Receptor Agonists Based on Naphthoquinone DerivativesTatsuma Nishioka, Kaori Endo-Umeda, Yuki Ito, et al.
Journal of Biological Rhythms|July 31, 2007
Multiple mechanisms regulate circadian expression of the gene for cholesterol 7alpha-hydroxylase (Cyp7a), a key enzyme in hepatic bile acid biosynthesisMitsuhide Noshiro, Emiko Usui, Takeshi Kawamoto, et al.
Toxicology|November 25, 2010
Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated miceJun Ozeki, Shigeyuki Uno, Michitaka Ogura, et al.
Journal of Lipid Research|January 9, 2008
Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemiaMichiyasu Ishizawa, Manabu Matsunawa, Ryutaro Adachi, et al.
Bioorganic & Medicinal Chemistry|May 29, 2007
Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonistsJun-Ichi Kasuga, Izumi Nakagome, Atsushi Aoyama, et al.
Science (New York, N.Y.)|May 23, 2002
Vitamin D receptor as an intestinal bile acid sensorMakoto Makishima, Timothy T Lu, Wen Xie, et al.
Pageof 74

Showing results (471-480 of 737) with videos related to

Sort By:
Pageof 74
Journal of Oncology|October 5, 2020
CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in NeuroblastomaKiyohiro Ando, Verna Cázares-Ordoñez, Makoto Makishima, et al.
Leukemia|January 17, 2012
CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitorsH Makishima, Y Sugimoto, H Szpurka, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2009
[Design and synthesis of peroxisome proliferator-activated receptor (PPAR) delta agonists and its implication to the driving force to elicit PPAR delta selectivity]Jun-Ichi Kasuga, Takuji Oyama, Izumi Nakagome, et al.
Chemmedchem|February 26, 2008
The first potent subtype-selective retinoid X receptor (RXR) agonist possessing a 3-isopropoxy-4-isopropylphenylamino moiety, NEt-3IP (RXRalpha/beta-dual agonist)Kayo Takamatsu, Atsushi Takano, Nobumasa Yakushiji, et al.
Molecules (Basel, Switzerland)|November 30, 2019
Synthesis and In Vitro Evaluation of Novel Liver X Receptor Agonists Based on Naphthoquinone DerivativesTatsuma Nishioka, Kaori Endo-Umeda, Yuki Ito, et al.
Journal of Biological Rhythms|July 31, 2007
Multiple mechanisms regulate circadian expression of the gene for cholesterol 7alpha-hydroxylase (Cyp7a), a key enzyme in hepatic bile acid biosynthesisMitsuhide Noshiro, Emiko Usui, Takeshi Kawamoto, et al.
Toxicology|November 25, 2010
Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated miceJun Ozeki, Shigeyuki Uno, Michitaka Ogura, et al.
Journal of Lipid Research|January 9, 2008
Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemiaMichiyasu Ishizawa, Manabu Matsunawa, Ryutaro Adachi, et al.
Bioorganic & Medicinal Chemistry|May 29, 2007
Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonistsJun-Ichi Kasuga, Izumi Nakagome, Atsushi Aoyama, et al.
Science (New York, N.Y.)|May 23, 2002
Vitamin D receptor as an intestinal bile acid sensorMakoto Makishima, Timothy T Lu, Wen Xie, et al.
Pageof 74